ARCHIVES

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

This article is from The Cancer Letter archive.

Vol. 21 No. 07 | February 17, 1995

Download PDF Visit The Full Archive

Related Articles

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches

February 3, 1989

NCI Unveils Checklist for Omics Studies

February 7, 2013

Rare Lung Disease Raises Risk Of Meningiomas

October 26, 2001

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009